Search for: "Pharmaceutical Associates, Inc." Results 381 - 400 of 1,890
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jun 2017, 11:15 am by Edward Smith
Jenssen Pharmaceuticals, Invokana’s manufacturer, also warns patients that this drug can increase their chances of suffering bone fractures and various allergic reactions. [read post]
8 Jun 2017, 3:27 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
15 Apr 2017, 8:47 pm by Patent Docs
Jonas Anderson, American University Washington College of Law, with a panel consisting of Jennifer Thomas of Hyman, Phelps & McNamara, PC, representing Pharmaceutical Care Management Association, et al. on amicus brief; Donald Ware of Foley Hoag... [read post]
12 Apr 2017, 7:13 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED April 10, 2017, Order) (Bryson, CJ) [read post]
10 Apr 2017, 3:47 am by Law Offices of Jeffrey S. Glassman
Additionally, the drug has been associated with various other serious psychological issues. [read post]
Recommendations: To minimize the potential risks associated with accepting manufacturer copay coupons, specialty pharmacies should implement policies and procedures to ensure that only eligible beneficiaries are allowed to use copay coupons. [read post]
The plaintiffs originally filed each of the subject eight lawsuits in California state court against the defendants Pfizer, Inc. and McKesson Corp., alleging that a pharmaceutical product, Lipitor, caused them to develop Type II diabetes and that, among other things, the defendants did not properly disclose the risks associated with Lipitor. [read post]
23 Feb 2017, 7:21 am by Altman & Altman
Pharmaceutical companies make billions in profits. [read post]
21 Feb 2017, 9:37 am by Green and Associates
 In a recent case, Forest Laboratories LLC, located in New York, New York, and its subsidiary, Forest Pharmaceuticals Inc., agreed in December 2016 to pay $38 million to resolve allegations that they violated the False Claims Act by paying "kickbacks" through payments and meals for alleged sham speaking programs to induce physicians to prescribe the drugs Bystolic®, Savella®, and Namenda®. [read post]
21 Feb 2017, 9:37 am by Green and Associates
 In a recent case, Forest Laboratories LLC, located in New York, New York, and its subsidiary, Forest Pharmaceuticals Inc., agreed in December 2016 to pay $38 million to resolve allegations that they violated the False Claims Act by paying "kickbacks" through payments and meals for alleged sham speaking programs to induce physicians to prescribe the drugs Bystolic®, Savella®, and Namenda®. [read post]
2 Feb 2017, 9:53 am by Kevin LaCroix
Prior to his judicial service, Judge Gorsuch also wrote an amicus brief for the United States Chamber of Commerce in Dura Pharmaceuticals, Inc. v. [read post]